By Siddhi Mahatole June 2 (Reuters) - Drug developer Cingulate said on Tuesday the U.S. Food and Drug Administration declined ...

The CRL comes after the FDA accepted the NDA for review in October 2025 and set a Prescription Drug User Fee Act target ...

The recalled patches were part of lot code 56841, with expiration 03/2028. They also had a National Drug Code (NDC) of ...

New paper-thin piezoelectric patch sensors designed for at-home stroke rehabilitation may soon revolutionize post-stroke care ...

Corsair Pharma's skin-worn patch designed to deliver the PAH treatment treprostinil appears to be working as intended, early ...